memoquin vs (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole
Mechanistic comparison of memoquin and (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole [Supplementary Concept] neutral analog of amyloid-binding thioflavin-T (BTA) that crosses based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
40%
Jaccard Similarity
41%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
memoquin and (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.400 means 40% of the combined target set is bound by both compounds. The IDF-weighted score of 0.408 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to memoquin
Similar to (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole
(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs lipocrine2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs retinal2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs retinol2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs 2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs phenothiazine2 targets